SATVI - after 10 years closing in on a new and  better vaccine to prevent tuberculosis.
The vision of the South African Tuberculosis Vaccine Initiative (SATVI) (www.satvi.uct.ac.za) is 'A World Without TB' and our mission is 'Innovative and high-quality TB vaccine research in Africa, to impact the global epidemic'. Over the last 10 years, our focus has been twofold: first, clinical trials of BCG and of new candidate vaccines, and second, complementary research that addresses critical questions in TB vaccine development. SATVI is now widely regarded as the leading TB vaccine clinical research site in the world.
South African TB Vaccine Initiative, Faculty of Health Sciences, University of Cape Town. willem.hanekom@uct.ac.za
Willem A
WA
Hanekom
Anthony
A
Hawkridge
Hassan
H
Mahomed
Thomas J
TJ
Scriba
Michele
M
Tameris
Jane
J
Hughes
Mark
M
Hatherill
Cheryl L
CL
Day
Gregory D
GD
Hussey
D000293:Adolescent; D000328:Adult; D001500:BCG Vaccine; D002986:Clinical Trials as Topic; D003299:Cooperative Behavior; D006801:Humans; D007223:Infant; D009169:Mycobacterium tuberculosis / Q000276:immunology; D012577:Schools, Medical; D013019:South Africa; D032581:Tuberculosis Vaccines; D014397:Tuberculosis, Pulmonary / Q000276:immunology / Q000517:prevention & control*; D014495:Universities
D001500:BCG Vaccine; D032581:Tuberculosis Vaccines